122 related articles for article (PubMed ID: 6517533)
1. Phase II trial of 10-deazaaminopterin for advanced hypernephroma.
Scher HI; Yagoda A; Ahmed T; Hollander P; Watson RC
Anticancer Res; 1984; 4(6):409-10. PubMed ID: 6517533
[TBL] [Abstract][Full Text] [Related]
2. Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate.
Krug LM; Ng KK; Kris MG; Miller VA; Tong W; Heelan RT; Leon L; Leung D; Kelly J; Grant SC; Sirotnak FM
Clin Cancer Res; 2000 Sep; 6(9):3493-8. PubMed ID: 10999734
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of 10-deaza-aminopterin in patients with advanced cancer.
Currie VE; Warrell RP; Arlin Z; Tan C; Sirotnak FM; Greene G; Young CW
Cancer Treat Rep; 1983 Feb; 67(2):149-54. PubMed ID: 6825121
[TBL] [Abstract][Full Text] [Related]
4. 10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancer.
Krug LM; Azzoli CG; Kris MG; Miller VA; Khokhar NZ; Tong W; Ginsberg MS; Venkatraman E; Tyson L; Pizzo B; Baez V; Ng KK; Sirotnak FM
Clin Cancer Res; 2003 Jun; 9(6):2072-8. PubMed ID: 12796370
[TBL] [Abstract][Full Text] [Related]
5. Final results of a phase I and pharmacokinetic study of gamma-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors.
Johansen M; Zukowski T; Hoff PM; Newman RA; Ni D; Hutto T; Abbruzzeese J; Berghorn E; Hausheer F; Madden T
Cancer Chemother Pharmacol; 2004 May; 53(5):370-6. PubMed ID: 15060739
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of 4'epi-adriamycin for advanced hypernephroma.
Benedetto P; Ahmed T; Needles B; Watson RC; Yagoda A
Am J Clin Oncol; 1983 Oct; 6(5):553-4. PubMed ID: 6577784
[TBL] [Abstract][Full Text] [Related]
7. A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative Group.
Schornagel JH; Verweij J; de Mulder PH; Cognetti F; Vermorken JB; Cappelaere P; Armand JP; Wildiers J; Clavel M; Kirkpatrick A
Ann Oncol; 1992 Mar; 3(3):223-6. PubMed ID: 1586620
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.
Beinart GA; Gonzalez-Angulo AM; Broglio K; Frye D; Walters R; Holmes FA; Gunale S; Booser D; Rosenthal J; Dhingra K; Young JA; Hortobagyi GN
Cancer Chemother Pharmacol; 2007 Jun; 60(1):61-7. PubMed ID: 17009032
[TBL] [Abstract][Full Text] [Related]
9. Controlled trial of methotrexate versus CH-1504 in the treatment of rheumatoid arthritis.
Castaneda O; Nair MG
J Rheumatol; 2006 May; 33(5):862-4. PubMed ID: 16652417
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma.
Pazdur R; Moore DF; Bready B; Giannone L; Maldonado A; Lin YG; Fueger RH; Winn RJ; Levin B
Ann Oncol; 1994 Sep; 5(7):646-8. PubMed ID: 7527654
[TBL] [Abstract][Full Text] [Related]
11. A combined chemo-endocrine treatment with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinoma.
Wada T; Houjou T; Kubo R; Yasutomi M; Kurita T
Anticancer Res; 1993; 13(6B):2465-7. PubMed ID: 8135483
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer.
Shum KY; Kris MG; Gralla RJ; Burke MT; Marks LD; Heelan RT
J Clin Oncol; 1988 Mar; 6(3):446-50. PubMed ID: 2832548
[TBL] [Abstract][Full Text] [Related]
13. A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy.
Vis AN; van der Gaast A; van Rhijn BW; Catsburg TK; Schmidt C; Mickisch GH
Cancer Chemother Pharmacol; 2002 Apr; 49(4):342-5. PubMed ID: 11914915
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma.
Motzer RJ; Rakhit A; Schwartz LH; Olencki T; Malone TM; Sandstrom K; Nadeau R; Parmar H; Bukowski R
Clin Cancer Res; 1998 May; 4(5):1183-91. PubMed ID: 9607576
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of 1,2,4-triglycidylurazol in patients with metastasized renal cell carcinoma.
Wagner H; Possinger K; Bremer K; Donhujsen-Ant R; Peukert M; Queisser W
Cancer Treat Rep; 1987 Feb; 71(2):209-10. PubMed ID: 3802118
[No Abstract] [Full Text] [Related]
16. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W
Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
[TBL] [Abstract][Full Text] [Related]
18. Phase I/II trial of temsirolimus combined with interferon alfa for advanced renal cell carcinoma.
Motzer RJ; Hudes GR; Curti BD; McDermott DF; Escudier BJ; Negrier S; Duclos B; Moore L; O'Toole T; Boni JP; Dutcher JP
J Clin Oncol; 2007 Sep; 25(25):3958-64. PubMed ID: 17761980
[TBL] [Abstract][Full Text] [Related]
19. Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.
Laurie SA; Pfister DG; Kris MG; Tong WP; Chronowski G; Pisters KM; Heelan RT; Sirotnak FM
Clin Cancer Res; 2001 Mar; 7(3):501-9. PubMed ID: 11297240
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of 10-Edam in patients with advanced colorectal carcinoma.
Kemeny N; Israel K; O'Hehir M
Am J Clin Oncol; 1990 Feb; 13(1):42-4. PubMed ID: 2305719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
